Similarly, in human-derived breast cancer cells, a higher proportion of CD24-/CD44 + subpopulation indicates stronger stemness, while a lower proportion of CD24-/CD44 + subpopulation suggests weaker stemness. Here, CD44 is linked to breast carcinoma.